Symmetry Medical to Report Second Quarter 2010 Financial Results on August 5, 2010

Wednesday, July 21, 2010 Corporate News J E 4

WARSAW, Ind., July 20 Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today that it will release second quarter 2010 financial results for the period ending July 3, 2010 before the market opens on Thursday, August 5, 2010. Symmetry Medical will host an accompanying conference call at 8:00 a.m. ET on Thursday, August 5, 2010.

A live Web cast of the conference call will be available online from the investor relations page of the Company's corporate Web site at The dial-in numbers are (866) 356-3093 for domestic callers and (617) 597-5381 for international. The reservation number for both is 23553266. After the live Web cast, the call will remain available on Symmetry Medical's Web site through November 5, 2010. In addition, a telephonic replay of the call will be available until August 19, 2010. The replay numbers are (888) 286-8010 for domestic callers and (617) 801-6888 for international callers. Please use reservation code 34068334.

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopaedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.

Contact: Symmetry Medical Inc. Fred L. Hite Senior Vice President Chief Financial Officer (574) 371-2218 Investors: The Ruth Group Nick Laudico/Zack Kubow (646) 536-7030/7020 Media: Jason Rando The Ruth Group (646) 536-7025

SOURCE Symmetry Medical Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Endo Pharmaceuticals to Announce Second Quarter 20...
Hartford Healthcare Corporation Retains Cymetrix f...